BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 12395898)

  • 1. Ductal and acinar differentiation in pancreatic endocrine tumors.
    Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
    Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth.
    Terada T; Kawaguchi M; Furukawa K; Sekido Y; Osamura Y
    Pathol Int; 2002 Nov; 52(11):740-6. PubMed ID: 12685552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ; Sandgren EP
    Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
    Tobita K; Kijima H; Chino O; Dowaki S; Kashiwagi H; Tanaka M; Ohtani Y; Inokuchi S; Makuuchi H
    Anticancer Res; 2001; 21(3C):2131-4. PubMed ID: 11501836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed acinar-endocrine carcinomas of the pancreas.
    Klimstra DS; Rosai J; Heffess CS
    Am J Surg Pathol; 1994 Aug; 18(8):765-78. PubMed ID: 8037290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.
    Hoorens A; Lemoine NR; McLellan E; Morohoshi T; Kamisawa T; Heitz PU; Stamm B; Rüschoff J; Wiedenmann B; Klöppel G
    Am J Pathol; 1993 Sep; 143(3):685-98. PubMed ID: 8362971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period.
    Terada T; Matsunaga Y; Maeta H; Endo K; Horie S; Ohta T
    Virchows Arch; 1999 Dec; 435(6):606-11. PubMed ID: 10628803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Insights Into Immunohistochemical Analysis For Acinar Cell Neoplasm of The Pancreas: Carboxypeptidase A2, Carboxypeptidase A1, and Glycoprotein 2.
    Ishimoto-Namiki U; Ino Y; Esaki M; Shimada K; Saruta M; Hiraoka N
    Am J Surg Pathol; 2023 May; 47(5):525-534. PubMed ID: 36815573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The establishment of a human pancreatic mixed ductal-endocrine carcinoma cell line].
    Hou M; Gao J; Liu T; Cui Q
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):422-6. PubMed ID: 11869555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total pancreatectomy for metachronous mixed acinar-ductal carcinoma in a remnant pancreas.
    Shonaka T; Inagaki M; Akabane H; Yanagida N; Shomura H; Yanagawa N; Oikawa K; Nakano S
    World J Gastroenterol; 2014 Sep; 20(33):11904-9. PubMed ID: 25206298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PET and PET-CT of malignant tumors of the exocrine pancreas].
    Reske SN
    Radiologe; 2009 Feb; 49(2):131-6. PubMed ID: 19219476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
    Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
    Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
    Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P
    Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
    Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
    Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
    Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
    Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.